Surprisingly, our data reveal that RV treatment selectively increases Nox5 expression in both A549 and H460 cells (Figs. 6A and 6C), suggesting that RV-induced ROS generation in cancer cells is likely attributable to increased Nox5 expression. This evidence concerns the gene NOX5 and cancer.